Skip to main content
. 2022 Apr 23;11(9):2371. doi: 10.3390/jcm11092371

Figure 3.

Figure 3

Forest plots for complement inhibition. (A) We observed statistically significantly lower systemic complement inhibition in patients with early to intermediate nonexudative AMD versus non-AMD controls (p = 0.03). (B) There was no statistically significant difference in systemic complement inhibition in patients with geographic atrophy versus non-AMD controls (p = 0.82). Blue diamonds denote the 95% confidence interval (CI); dashed tails denote the 95% prediction interval for this multi-level random-effects model.